Astellas Looks To India As Part Of Japanese Drug Maker Trend
This article was originally published in PharmAsia News
Executive Summary
Astellas Pharma of Japan is considering becoming active in India as Japanese drug makers look to that country to expand sales and manufacture their products. A consultant said Japanese companies increasingly are looking to expand in India because the country is particularly suitable for pharmaceutical and chemical companies. Daiichi Sankyo is buying Ranbaxy Laboratories, Eisai already is expanding manufacturing and sales operations into India, both an indication the trend is likely to accelerate. (Click here for more - a subscription may be required